| 1 |
30399481 | Investigation on drug-binding in heme pocket of CYP2C19 with UV-visible and resonance Raman spectroscopies. | 2019 Feb 15 |
1 |
| 2 |
31164617 | Study Protocol for a Pilot, Open-Label, Prospective, and Observational Study to Evaluate the Pharmacokinetics of Drugs Administered to Patients during Extracorporeal Circulation; Potential of In Vivo Cytochrome P450 Phenotyping to Optimise Pharmacotherapy. | 2019 May 13 |
1 |
| 3 |
28686070 | Effects of aging and rifampicin pretreatment on the pharmacokinetics of human cytochrome P450 probes caffeine, warfarin, omeprazole, metoprolol and midazolam in common marmosets genotyped for cytochrome P450 2C19. | 2018 Jul |
1 |
| 4 |
29357810 | Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells. | 2018 |
2 |
| 5 |
27712037 | In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice. | 2017 Feb |
1 |
| 6 |
28215634 | Isolation and expansion of human pluripotent stem cell-derived hepatic progenitor cells by growth factor defined serum-free culture conditions. | 2017 Mar 15 |
1 |
| 7 |
25808545 | Microbial-derived lithocholic acid and vitamin K2 drive the metabolic maturation of pluripotent stem cells-derived and fetal hepatocytes. | 2015 Jul |
1 |
| 8 |
25940755 | Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients. | 2015 Nov |
1 |
| 9 |
21415279 | Influence of different proton pump inhibitors on activity of cytochrome P450 assessed by [(13)C]-aminopyrine breath test. | 2012 Mar |
1 |
| 10 |
22483397 | High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma. | 2012 May 1 |
1 |
| 11 |
21352268 | Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions? | 2011 Oct |
1 |
| 12 |
21392639 | Clopidogrel-drug interactions. | 2011 Mar 15 |
1 |
| 13 |
21771377 | [Interaction between clopidogrel and proton pump inhibitors]. | 2011 |
2 |
| 14 |
19513837 | Omeprazole induces gastric permeability to digoxin. | 2010 May |
1 |
| 15 |
24688155 | Pharmacokinetic interaction between fluoxetine and omeprazole in healthy male volunteers: a prospective pilot study. | 2010 Dec |
1 |
| 16 |
20002088 | Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. | 2009 Dec |
1 |
| 17 |
14664653 | Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know. | 2003 |
2 |
| 18 |
11742579 | Interindividual variations in levels and activities of cytochrome P-450 in liver microsomes of Chinese subjects. | 2001 Mar |
1 |
| 19 |
10215728 | Effect of CYP2C19 polymorphism on serum levels of vitamin B12 in patients on long-term omeprazole treatment. | 1999 Apr |
2 |
| 20 |
9224780 | Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms. | 1997 Jul |
3 |
| 21 |
9361171 | Lack of effect of omeprazole in oral acenocoumarol anticoagulant therapy. | 1997 Oct |
1 |
| 22 |
8827397 | Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole. | 1996 Jul |
3 |
| 23 |
7917780 | Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism. | 1994 Jun |
5 |
| 24 |
12959268 | Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. | 1993 Dec |
3 |
| 25 |
1344831 | [Omeprazole and liver functions]. | 1992 Sep-Oct |
1 |
| 26 |
1748033 | Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole. | 1991 Dec |
3 |
| 27 |
3485990 | Inhibition of human liver cytochrome P-450 by omeprazole. | 1986 Mar |
3 |